Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02490332
Other study ID # 2015-112556
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date February 2016
Est. completion date November 2, 2020

Study information

Verified date November 2020
Source Zealand University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The prevalence of otitis media among Greenlandic children is one of the highest in the world and twenty per cent of schoolchildren have impaired hearing in the frequencies for normal speech. Yet, there are no national guidelines to ensure prevention and treatment of recurrent acute otitis media and chronic otitis media with effusion and impaired hearing in Greenlandic children. International studies from the developed part of the world have shown that otitis prone children may benefit from tubulation of the tympanic membrane. However, it is unknown if these results can be applied to Greenlandic children. This PhD project will conduct a randomised controlled trial comparing tubulation of the tympanic membrane, in Greenlandic children aged 9-36 months with recurrent acute otitis media and/or chronic otitis media with effusion, to conservative treatment. The children will be followed for two years. Outcome measures will include number of visits to health clinics, number of tympanic membrane perforations, number of episodes with acute otitis media according to medical records, Quality of life, measured by the validated questionnaires OM6 and Caregiver Impact Questionnaire, number of episodes where per oral or intravenous antibiotics have been administered according to medical records and serious adverse events The trial will be conducted in collaboration with the Greenlandic health authorities and Copenhagen Trial Unit. With this trial the investigators hope to decrease the number of episodes with acute otitis media, the number of Greenlandic children with chronic perforations of the tympanic membrane and hearing impairment and increase quality of life. The results will add important knowledge to the effect of ventilation tube treatment also in an international aspect. There are to date only less than a handful of high quality studies concerning this issue on an international basis. The study will be among the first addressing this problem among populations with high risk of otitis media and is also of interest to other indigenous populations and the developing part of the world.


Recruitment information / eligibility

Status Terminated
Enrollment 31
Est. completion date November 2, 2020
Est. primary completion date November 2, 2020
Accepts healthy volunteers No
Gender All
Age group 9 Months to 36 Months
Eligibility Inclusion criteria: - Children aged 9-36 months. - Children with at least one Greenlandic born parent with at least one Greenlandic born parent - American Society of Anaesthesiologists physical status classification class 1 and 2 - B- or C2 - type curve measured by tympanometry at two visits three-four months apart or three episodes of acute otitis media in six months according to medical records or four episodes of acute otitis media in 12 months according to medical records - Signed informed consent, signed by the legal guardian Exclusion criteria - Children with orofacial cleft, Downs syndrome or known generalised immune deficiency - American Society of Anaesthesiologists physical status classification class > 2. - Lack of signed informed consent, signed by the legal guardian. Description of experimental and control intervention Experimental intervention: The intervention group will be treated with bilateral Donaldson ventilation tubes administered in general anaesthesia Control intervention: The control intervention is based on the current practice in Greenland, which includes systemic antibiotic treatment as well as aural toilette and topical antibiotics. Ventilation tube insertion during the study period is not accepted in the control group. Children in the intervention group as well as the control group will be seen once a year by the visiting ear-nose-and throat (ENT)-specialist and have a final consultation after at least two years after randomisation.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ventilation tube treatment
Tympanostomy

Locations

Country Name City State
Greenland Aasiaat Regional Hospital Aasiaat Danmark
Greenland Ilulissat Regional Hospital Ilulissat Danmark
Greenland Nuuk Health Center Nuuk Danmark
Greenland Qaqortoq Regional Hospital Qaqortoq
Greenland Sisimiut Regional Hospital Sisimiut Danmark
Greenland Tasiilaq Health Center Tasiilaq Danmark

Sponsors (3)

Lead Sponsor Collaborator
Zealand University Hospital Copenhagen Trial Unit, Center for Clinical Intervention Research, Government of Greenland, Agency for Health and Prevention

Country where clinical trial is conducted

Greenland, 

Outcome

Type Measure Description Time frame Safety issue
Other Number of episodes of aural discharge According to medical records Two years after randomisation
Other Serious adverse events Any adverse event that results in death, is life-threatening, requires hospitalisation or prolongation of existing hospitalisation, or results in persistent or significant disability or incapacity. During the trial
Primary Number of visits to health clinic Assessed by investigating medical records. Two years after randomisation
Secondary Number of episodes of acute otitis media According to medical records Two years after randomisation
Secondary Quality of life Measured by validated questionnaires OM6 and Caregiver Impact Questionnaire Assessed at baseline, three months after randomisation, one year after randomisation, and at the end of the trial two years after randomisation
Secondary Number of episodes where per oral or intravenous antibiotics have been administered According to medical records Two years after randomisation
Secondary Proportion of children with uni- or bilateral tympanic membrane perforations Based on otoscopical photos, which will be anonymised and evaluated by an ENT-specialist without knowledge of the intervention Two years after randomisation
See also
  Status Clinical Trial Phase
Completed NCT04016051 - Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections Phase 3
Completed NCT02452164 - Family MobilePhone Otoscopy in Diagnostics of Otitis Media N/A
Completed NCT01199016 - Effect of Prevnar 13 on Ear Infections in Children Phase 4
Terminated NCT00778063 - Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients N/A
Completed NCT00195611 - Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media Phase 4
Recruiting NCT03722160 - Clinical Study of the Solo Tympanostomy Tube Device N/A
Recruiting NCT04447521 - Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium
Active, not recruiting NCT05127161 - Broad Implementation of Outpatient Stewardship N/A
Completed NCT02600559 - Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes Phase 3
Completed NCT01444391 - inVENT-visIOn Study N/A
Enrolling by invitation NCT01437436 - The Effect of Obesity on Ventilation Tube Insertion N/A
Completed NCT01003210 - Homeopathic Ear Drops for Otitis Media Study N/A
Completed NCT00768534 - Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media N/A
Recruiting NCT00393159 - The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children Phase 4
Completed NCT00617682 - Maternal Immunization To Prevent Infant Otitis Media Phase 1/Phase 2
Withdrawn NCT00956748 - N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media Phase 4
Withdrawn NCT01908764 - Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery Phase 1
Recruiting NCT01619462 - Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children Phase 3
Completed NCT02616458 - The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population N/A
Completed NCT00781521 - Safety and Efficacy of Floxin Otic Solution in the Treatment of Acute Otitis Media in Children Phase 3